CDSCO UID MFG/IVD/2019/000052_7b427b77d3c432cf1a7b4761fa5eefd7_b36db40c491fef8913a5b18dd7924173
Blood Cell Count Analyser
KARWA ENTERPRISES PRIVATE LIMITED·Device Class Class A·India CDSCO
Registration details
- UID
- MFG/IVD/2019/000052_7b427b77d3c432cf1a7b4761fa5eefd7_b36db40c491fef8913a5b18dd7924173
- Device class
- Class A
- License holder
- KARWA ENTERPRISES PRIVATE LIMITED
- Approving authority
- North West Delhi Division
- Product information
- To run tests on blood samples to differentiate and quantify formed elements in the blood
Similar products (3)
Other products with the same name or brand
Blood Cell Count Analyser
Hospital Equipment Manufacturing Company
Class A
Blood Cell Count Analyser
ASPEN BIOMEDICAL PRIVATE LIMITED
Class A
Blood Cell Count Analyser
ASPEN LABORATORIES PRIVATE LIMITED
Class A
Other products from KARWA ENTERPRISES PRIVATE LIMITED
Products from the same license holder (10 products)
Malaria Pf Antigen Rapid Test
Class C
Syphilis Rapid Strip Test
Class D
Drugs of Abuse Rapid Test
Class C
Dengue NS1 ELISA Test Kit
Class C
HCV Rapid Card Test Kit
Class D
Syphilis Rapid Card Test
Class D
Typhoid Antigen Rapid Card Test
Class C
Syphilis ELISA Kit
Class D
KARWA COVID-19 RT-LAMP DIAGNOSTIC KIT
Class C
HIV ELISA Test Kit
Brand: 3rd Generation
Class D
About this record
Blood Cell Count Analyser is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2019/000052_7b427b77d3c432cf1a7b4761fa5eefd7_b36db40c491fef8913a5b18dd7924173. The license holder is KARWA ENTERPRISES PRIVATE LIMITED, and it is classified as Device Class Class A. The approving authority is North West Delhi Division.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.